The SELECT trial found semaglutide reduces major cardiovascular events by 20 percent in high-risk patients
Key Takeaway: Success on a GLP-1 or GIP medication depends on listening to your body and making small, consistent adjustments to your daily habits
L-carnitine, the parent compound of acetyl-L-carnitine, might enhance the anticoagulant effects of acenocoumarol, an oral anticoagulant that is similar to warfarin, but shorter-acting
Future of transdermal GLP-1 delivery Research on true pharmaceutical-grade transdermal GLP-1 delivery is underway: Microneedle array patches : Use tiny dissolvable needles to deliver medication just below the skin Enhanced transdermal systems : Employ special technologies to improve skin penetration Controlled-release formulations : Designed for sustained delivery over days or weeks Animal studies have shown promising results, with some experimental patches achieving blood levels comparable to those of injections
Many patients describe a gradual diminishment of hunger cues, reduced food cravings (particularly for high-calorie or high-fat foods), and earlier satiety during meals
Not all patients have compatible smart phones, or enough mobile data or internet access, for all CGM sensors to suit all women